TREATMENT OF EXUDATIVE AGE-RELATED MACULAR DEGENERATION WITH RANIBIZUMAB COMBINED WITH KETOROLAC EYEDROPS OR PHOTODYNAMIC THERAPY.
第一作者:
Francesco,Semeraro
第一单位:
*Department of Neurological and Vision Sciences, Eye Clinic, University of Brescia, Brescia, Italy; †Humanitas Clinical Institute, Milan, Italy; ‡Department of Ophthalmology, Second University of Naples, Naples, Italy; and §Department of Health Sciences, Eye Clinic, University of Molise, Campobasso, Italy.
作者:
主题词
老年人(Aged);老年人, 80以上(Aged, 80 and over);血管生成抑制剂(Angiogenesis Inhibitors);消炎药, 非甾类(Anti-Inflammatory Agents, Non-Steroidal);综合疗法(Combined Modality Therapy);药物疗法, 联合(Drug Therapy, Combination);渗出液和滤出液(Exudates and Transudates);女(雌)性(Female);人类(Humans);玻璃体内注射(Intravitreal Injections);酮咯酸(Ketorolac);男(雄)性(Male);中年人(Middle Aged);眼药水(Ophthalmic Solutions);光化学疗法(Photochemotherapy);光敏感药(Photosensitizing Agents);卟啉类(Porphyrins);前瞻性研究(Prospective Studies);血管内皮生长因子A(Vascular Endothelial Growth Factor A);视敏度(Visual Acuity);湿性黄斑变性(Wet Macular Degeneration)
DOI
10.1097/IAE.0000000000000525
PMID
25784358
发布时间
2022-03-16
- 浏览14

Retina (Philadelphia, Pa.)
1547-54页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文